Cargando…
Novel and versatile artificial intelligence algorithms for investigating possible GHSR1α and DRD1 agonists for Alzheimer's disease
Hippocampal lesions are recognized as the earliest pathological changes in Alzheimer's disease (AD). Recent researches have shown that the co-activation of growth hormone secretagogue receptor 1α (GHSR1α) and dopamine receptor D1 (DRD1) could recover the function of hippocampal synaptic and cog...
Autores principales: | Tang, Zi-Qiang, Zhao, Lu, Chen, Guan-Xing, Chen, Calvin Yu-Chian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694922/ https://www.ncbi.nlm.nih.gov/pubmed/35423219 http://dx.doi.org/10.1039/d0ra10077c |
Ejemplares similares
-
Signaling of ghrelin at GHSR1b and OX1R receptor heterodimers
por: Wang, Qiuling, et al.
Publicado: (2021) -
Genetic deletion of the ghrelin receptor (GHSR) impairs growth and blunts endocrine response to fasting in Ghsr-IRES-Cre mice
por: Peris-Sampedro, Fiona, et al.
Publicado: (2021) -
OR0303 Syndecans Enhance Ghrelin-Induced GHSR1a Signaling
por: Prins, Karina, et al.
Publicado: (2023) -
Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS
por: Gameli, Prince Sellase, et al.
Publicado: (2023) -
Potential Retinoid X Receptor Agonists for Treating Alzheimer's Disease from Traditional Chinese Medicine
por: Chen, Kuan-Chung, et al.
Publicado: (2014)